© 2023 MJH Life Sciences and Drug Topics. All rights reserved.
© 2023 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 10, 2023
The study could lead to early diagnosis and treatment of age-related macular degeneration.
January 04, 2023
The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.
December 27, 2022
According to the company, clinical outcomes for 78 dry eye patients treated at a single center, the Cleveland Eye Clinic, showcased the duration of efficacy of a single, first-time treatment of MGD using the TearCare System.
November 22, 2022
Mount Sinai study is the first to identify that heart attack, stroke and heart failure are linked to a specific type of age-related macular degeneration.
November 11, 2022
According to a study, use is linked to a lower prevalence of age-related macular degeneration in European populations.
October 24, 2022
According to NEXGEL, the patch is expected be available for ophthalmologists to offer to their patients in the first half of 2023.
September 28, 2022
The authors noted that the proportion of patients losing fewer than 15 letters from the baseline BCVA score in the study eye was comparable between the two groups.
September 07, 2022
Using 7-methylxanthine may be key to slowing myopia in pediatric cases.
September 06, 2022
Patients who received the chemotherapies paclitaxel and docetaxel were at an increased risk of adverse events of the eye.
September 05, 2022
ONS-5010 is an investigational ophthalmic formulation of bevacizumab under development to be administered as an intravitreal injection for the treatment of wet AMD and other retinal diseases.